Literature DB >> 19332201

Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non-ST-elevation acute coronary syndromes undergoing diagnostic angiography.

Tracy Y Wang1, Min Zhang, Yuling Fu, Paul W Armstrong, L Kristin Newby, C Michael Gibson, David J Moliterno, Frans Van de Werf, Harvey D White, Robert A Harrington, Matthew T Roe.   

Abstract

BACKGROUND: Because acute occlusion of coronary arteries supplying the inferolateral myocardium frequently eludes standard 12-lead electrocardiogram (ECG) diagnosis, these patients may present as non-ST-segment elevation acute coronary syndromes (NSTE-ACS).
METHODS: We examined culprit artery occlusion among 1,957 NSTE-ACS patients in the Platelet IIb/IIIa Antagonism for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network trial who underwent diagnostic coronary angiography. We compared baseline characteristics, electrocardiographic findings, in-hospital treatment, and long-term outcomes between patients with and without occluded culprit arteries.
RESULTS: The culprit artery was occluded in 528 (27%) patients. Culprit lesions were more frequently identified in the inferolateral territory among patients with an occluded culprit artery (63%) compared with those with a nonoccluded artery (45%, P < .0001). Patients with an occluded culprit artery were younger, more often male, and more likely to have had a prior myocardial infarction. Despite similar in-hospital treatment, patients with an occluded culprit artery had larger infarcts (median peak creatine kinase-MB 4.3 vs 2.1 x upper limit of normal, P < .0001) and higher risk-adjusted 6-month mortality (hazard ratio 1.72, 95% CI 1.07-2.79).
CONCLUSIONS: More than 25% of NSTE-ACS patients had an occluded culprit artery on angiography. These patients may represent ST-segment elevation myocardial infarction equivalents; thus, improved early risk stratification techniques would help more rapidly triage these high-risk patients to an early invasive management strategy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19332201     DOI: 10.1016/j.ahj.2009.01.004

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  27 in total

1.  Time for a new paradigm shift in myocardial infarction.

Authors:  Emre K Aslanger; H Pendell Meyers; Stephen W Smith
Journal:  Anatol J Cardiol       Date:  2021-03       Impact factor: 1.596

2.  Novel ECG changes in acute coronary syndromes. Would improvement in the recognition of 'STEMI-equivalents' affect time until reperfusion?

Authors:  Joshua Wall; Leigh D White; Astin Lee
Journal:  Intern Emerg Med       Date:  2016-12-31       Impact factor: 3.397

3.  Clinical characteristics of occluded culprit arteries and collaterals in patients with non-ST-segment elevation myocardial infarction and impact on clinical outcomes.

Authors:  Hui-Jeong Hwang; Chang-Bum Park; Jin-Man Cho; Eun-Sun Jin; Il Suk Sohn; Dong-Hee Kim; Chong-Jin Kim
Journal:  Exp Ther Med       Date:  2018-08-13       Impact factor: 2.447

Review 4.  [Thrombus aspiration in patients with acute myocardial infarction : Scientific evidence and guideline recommendations].

Authors:  T Stiermaier; S de Waha; G Fürnau; I Eitel; H Thiele; S Desch
Journal:  Herz       Date:  2016-03-15       Impact factor: 1.443

5.  Evidence for a novel racemization process of an asparaginyl residue in mouse lysozyme under physiological conditions.

Authors:  K Ueno; T Ueda; K Sakai; Y Abe; N Hamasaki; M Okamoto; T Imoto
Journal:  Cell Mol Life Sci       Date:  2005-01       Impact factor: 9.261

6.  Incidence and distribution of occluded culprit arteries and impact of coronary collaterals on outcome in patients with non-ST-segment elevation myocardial infarction and early invasive treatment strategy.

Authors:  Philipp Bahrmann; Justus Rach; Steffen Desch; Gerhard C Schuler; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2010-12-17       Impact factor: 5.460

7.  The presence of angiographic collaterals in non-ST elevation myocardial infarction is a predictor of long-term clinical outcomes.

Authors:  Angela M Kloepfer; Lewis C Lipson; Ellen C Keeley
Journal:  Catheter Cardiovasc Interv       Date:  2013-06-25       Impact factor: 2.692

8.  Infarct artery distribution and clinical outcomes in occluded artery trial subjects presenting with non-ST-segment elevation myocardial infarction (from the long-term follow-up of Occluded Artery Trial [OAT]).

Authors:  Venu Menon; Witold Ruzyllo; Antonio C Carvalho; Jose Marconi Almeida de Sousa; Sandra A Forman; Krystyna Jaworska; Gervasio A Lamas; Marek Roik; Christophe Thuaire; Yoav Turgeman; Judith S Hochman
Journal:  Am J Cardiol       Date:  2013-01-22       Impact factor: 2.778

9.  Detection of acute coronary occlusion in patients with acute coronary syndromes presenting with isolated ST-segment depression.

Authors:  Mj Daly; Dd Finlay; D Guldenring; Cd Nugent; A Tomlin; B Smith; Aaj Adgey; Mt Harbinson
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2012-06

10.  Incidence and impact of totally occluded culprit coronary artery in patients with non-ST segment elevation myocardial infarction acute coronary syndrome.

Authors:  Sherif W Ayad; Tarek H El Zawawy; Mohamed I Lotfy; Ahmed M Naguib; Ahmed M El Amrawy
Journal:  Egypt Heart J       Date:  2021-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.